TRP Shares Tissue Repair Ltd
ASX · ASXLast in our picks 2026-10-03 — not in the current list; analysis below is from that screen
Deep-value biotech with asymmetric rebound potential if development milestones improve.
Signal breakdown
- ▸Very depressed valuation leaves optionality, but liquidity is limited.
- ▸Above 50-day MA (+5.93%)
- ▸Volume 1.62× average — accumulation
- ▾Near 52-week low (8.2% of range)
Is TRP a buy right now?
Trend: TRP is trading above the 50-day average (+0.00%), RSI 41 — neutral momentum, with a 3-month return of +8.43%.
Valuation & quality: Tissue Repair Ltd trades on forward P/E -1.1, price-to-book 0.62; fundamentals show net margin -179.3%, return on equity -47.3%, revenue growth -19.7% year on year.
Our screen: BUY (score 2) — Deep-value biotech with asymmetric rebound potential if development milestones improve.
Computed from end-of-day data; not personal advice.
12-month price chart
Monthly returns
| Mar 26 | Apr 26 | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|---|---|
| -11.10% | -18.70% | -15.40% | -9.10% | -10.00% | +0.00% | +0.00% | +0.00% |
Fundamentals
Technical signals
About Tissue Repair Ltd
Tissue Repair Ltd, a clinical stage biopharmaceutical company, develops advanced wound healing products for chronic wounds and aesthetic procedure aftercare in Australia.
Sector: Healthcare · Industry: Biotechnology · Australia · Website
Related Biotech picks
Browse: all ASX stocks · Biotech picks · today's movers
Market data from end-of-day feeds; AI-generated research for educational purposes only — not investment advice.